CareDx (CDNA) Misses Q4 EPS by 6c

CareDx (NASDAQ: CDNA) reported Q4 EPS of ($0.40), $0.06 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $7.44 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• CareDx completes Naveris acquisition, adding cancer MRD testing
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
• CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific